GGrantIndex
← Search

Central IRB Services for NIAID Coronavirus COVID-19 OWS ACTIV-3 Clinical Trial

$718,961N02FY2020AINIH

Medical Science & Computing, Llc, Rockville MD

Investigators

Abstract

The purpose of this funding is to provide the Central Institutional Review Board (IRB) services for the Coronavirus COVID-19 ACTIV-3 trial.

View original record on NIH RePORTER →